We have received text from H.R. 8159: Gynecologic Pain Management Study Act. This bill was received on 2026-03-30, and currently has 23 cosponsors.
Here is a short summary of the bill:
This bill, titled the Gynecologic Pain Management Study Act , aims to direct the Secretary of Health and Human Services to conduct a comprehensive study examining the barriers that prevent healthcare providers from offering, and patients from accessing, effective pain management methods during gynecologic procedures. The key components of the bill include:
Study Overview
The study will assess various factors that may limit access to pain management options. These factors could include issues related to:
- Insurance coverage
- Provider training
- Availability of resources
Stakeholder Engagement
While conducting the study, the Secretary is required to consult with a range of stakeholders to gather diverse insights. These stakeholders will include:
- Patients and patient advocacy organizations
- Licensed reproductive healthcare providers
- Professional medical societies
- Public health experts
- Health equity experts representing marginalized communities
- Medical device manufacturers and innovators
Reporting Requirements
Within 24 months of the bill's enactment, the Secretary must submit a report to two congressional committees: the Committee on Energy and Commerce of the House of Representatives, and the Committee on Health, Education, Labor, and Pensions of the Senate. This report will include:
- The findings from the study regarding barriers to pain management methods
- Any recommendations for administrative or legislative actions based on those findings
Definitions
For the purposes of the bill, several key terms are defined:
- Pain management methods: These refer to techniques or strategies used to prevent, reduce, or manage physical pain associated with medical procedures.
- Secretary: This term refers to the Secretary of Health and Human Services.
The overall aim of the bill is to better understand and potentially improve the access and effectiveness of pain management during gynecological procedures, impacting both healthcare providers and patients.
Relevant Companies
- None found
Representative Yassamin Ansari Bill Proposals
Here are some bills which have recently been proposed by Representative Yassamin Ansari:
- H.R.8160: Premenstrual Dysphoric Disorder Awareness and Research Act of 2026
- H.R.8159: Gynecologic Pain Management Study Act
- H.R.8158: Reproductive Healthcare Leave Act
- H.R.7483: Dual Hatting Limitation Act of 2026
- H.R.7347: Stop Inhumane Conditions in ICE Detention Act of 2026
- H.R.7346: Drain ICE Act of 2026
You can track bills proposed by Representative Yassamin Ansari on Quiver Quantitative's politician page for Ansari.
Representative Yassamin Ansari Net Worth
Quiver Quantitative estimates that Representative Yassamin Ansari is worth $4.4M, as of April 1st, 2026. This is the 178th highest net worth in Congress, per our live estimates.
Ansari has approximately $0 invested in publicly traded assets which Quiver is able to track live.
You can track Representative Yassamin Ansari's net worth on Quiver Quantitative's politician page for Ansari.
2026 Arizona's 3rd Congressional District Election
There has been approximately $14,036,167 of spending in Arizona's 3rd congressional district elections over the last two years, per our estimates.
Approximately $10,847,380 of this has been from outside spending by PACs and Super PACs. Some of the groups who are spending money in this race include:
- PROTECT PROGRESS ($2,735,294)
- DMFI PAC ($1,396,349)
- VICTORY PAC ($969,411)
- CHC BOLD PAC ($942,293)
- MAINSTREAM DEMOCRATS PAC ($811,225)
The rating for this race is currently "Solid D".
You can track this election on our matchup page for the 2026 Arizona's 3rd congressional district election.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
